IN-VIVO AND EX-VIVO METHODS: ADVANCING THE FRONTIERS OF OCULAR PHARMACOLOGICAL RESEARCH
AbstractPharmacological research is a complex and challenging field that seeks to understand the effects of drugs on living organisms. In-vivo and ex-vivo methods are two of the most essential tools used in pharmacological research, each with its own advantages and disadvantages. In-vivo methods involve testing drugs in living organisms, typically animals. This type of research can provide valuable information about the effects of drugs on the entire organism, including its metabolism, distribution, and elimination. However, in-vivo research can be expensive, time-consuming, and ethically challenging. Ex-vivo methods involve testing drugs on isolated tissues or cells. This type of research can provide more detailed information about the mechanisms of action of drugs, but it needs to consider the drug’s effects on the entire organism. The use of in-vivo and Ex-vivo methods together can provide a complete understanding of the effects of drugs. In-vivo methods can be used to identify potential new drugs, while ex-vivo methods can be used to study the mechanisms of action of drugs and to optimize their dosage and delivery. The use of in-vivo and ex-vivo methods has advanced the frontiers of pharmacological research in several ways. For example, In-vivo methods, such as optical coherence tomography and fund us imaging, allow for non-invasive imaging of the living eye. Ex-vivo methods, including histology and electron microscopy, provide high-resolution images of ocular tissues in a controlled laboratory setting. The use of in-vivo and ex-vivo methods is likely to advance the frontiers of pharmacological research in the years to come.
Article Information
8
78-86
896 KB
200
English
IJPSR
Shubhangi Shelar, Nigar Kadar Mujawar and Snehal S. Chakorkar *
Department of Pharmacology, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, Maharashtra, India.
snehalchakorkar@gmail.com
19 May 2023
02 August 2023
21 November 2023
10.13040/IJPSR.0975-8232.15(1).78-86
01 January 2024